Cell division is one of the most fundamental and complex processes underpinning life. In human cells, thousands of molecules ...
Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...
Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...
Bicistronic CD19/CD22-directed CAR-T cell therapy achieved high remission rates and durable responses in pediatric B-ALL patients. One-year EFS and OS rates were 75.5% and 93.5%, respectively, with ...
Curocell, an immuno-oncology cell therapy developer, has secured approval for RIMQARTO® Inj., South Korea’s first domestically developed CAR-T therapy ...
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s Non-Hodgkins lymphoma (NHL). Long-term evaluable patients demonstrate ongoing ...
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (INKT) cell therapies, today announced the publication of another landmark case in Nature’s Oncogene describing a complete and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results